HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $26,725,247 | +289.0% | 234,844 | +111.5% | 0.55% | +284.5% |
| Q3 2022 | $6,871,000 | -22.4% | 111,023 | -0.0% | 0.14% | -18.9% |
| Q2 2022 | $8,857,000 | -24.2% | 111,041 | 0.0% | 0.18% | -6.4% |
| Q1 2022 | $11,683,000 | -70.7% | 111,041 | -70.0% | 0.19% | -67.8% |
| Q4 2021 | $39,940,000 | -70.0% | 370,643 | -69.5% | 0.58% | -70.8% |
| Q3 2021 | $133,129,000 | +4.9% | 1,215,342 | -10.3% | 1.98% | +5.2% |
| Q2 2021 | $126,914,000 | +29.9% | 1,355,340 | +27.7% | 1.89% | +28.5% |
| Q1 2021 | $97,719,000 | +38.4% | 1,061,697 | +10.0% | 1.47% | +13.3% |
| Q4 2020 | $70,597,000 | -0.5% | 965,097 | +5.6% | 1.30% | -17.7% |
| Q3 2020 | $70,974,000 | +8.0% | 913,671 | -22.8% | 1.57% | +0.1% |
| Q2 2020 | $65,738,000 | +285.0% | 1,182,759 | +105.2% | 1.57% | +210.3% |
| Q1 2020 | $17,076,000 | – | 576,488 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |